Shayna Sarosiek

38PUBLICATIONS
67CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersAutoimmunityHumoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 08, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.

|Mar 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Jorge J Castillo, Andrew R Branagan, Alberto Guijosa

|Feb 03, 2026
Off-trial outcomes of zanubrutinib in Waldenström macroglobulinemia: the prognostic impact of CXCR4 and TP53 alterations.

Alberto Guijosa, Nicholas Tsakmaklis, Margaret Kobs

|Jan 22, 2026
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia.

Shayna Sarosiek, Jorge J Castillo, Zachary R Hunter

|Oct 20, 2025
BCL-2 inhibition in Waldenström macroglobulinaemia and marginal zone lymphoma.

Shayna Sarosiek, Uriel Suarez, Maria Fernandez-Turizo

|Sep 03, 2025
Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as outpatient versus inpatient.

Ana Maria Avila Rodriguez, Xiao Hu, Cindy Varga

Pageof 7

Frequent Collaborators

25 joint publications

Jorge J Castillo

20 joint publications

Steven P Treon

12 joint publications

Vaishali Sanchorawala

10 joint publications

Zachary R Hunter